Literature DB >> 7468804

Hormone-stimulated release of pancreatic polypeptide before and after vagotomy in dogs.

S Guzman, J Lonovics, P G Devitt, K E Hejtmancik, P L Rayford, J C Thompson.   

Abstract

Concentrations of pancreatic polypeptide (PP) in peripheral blood were measured before, during, and after infusions of graded doses of synthetic human gastrin I (SHG-I), cholecystokinin 99% pure (CCK-99%), CCK octapeptide (CCK-OP), and pure natural porcine secretin in six dogs with gastric and duodenal fistulas. Studies were repeated after truncal vagotomy. Significant increases in concentrations of PP were found with 1 microgram . kg-1 . h-1 of SHG-I, 0.25 and 1.0 microgram . kg-1 . h-1 of CCK-99%, and 0.06 and 0.25 micrograms . kg-1 . h-1 of CCK-OP. Significant increases persisted after vagotomy, except at the lower dose of CCK-OP. Postvagotomy responses were significantly less than prevagotomy, except at the higher doses of CCK-99% and CCK-OP. Pure secretin did not change concentrations of PP in blood before or after vagotomy. The most potent stimulant for PP release on a molar basis was CCI-99%, followed by CCK-OP and SHG-I. The results suggest that cholinergic and humoral agents of the gastrin-cholecystokinin family interact in the normal physiological response of PP to food and that, in dogs, CCK-like peptides are more potent than gastrin.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7468804     DOI: 10.1152/ajpgi.1981.240.2.G114

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

1.  Relationship of periodic pancreatic secretion and gallbladder contraction to plasma cholecystokinin in dogs.

Authors:  D F Magee; R F Murphy; S Naruse
Journal:  Ir J Med Sci       Date:  1988-08       Impact factor: 1.568

2.  Neurohumoral control of gallbladder motility in healthy subjects and diabetic patients with or without autonomic neuropathy.

Authors:  S Fiorucci; R Bosso; L Scionti; S DiSanto; B Annibale; G Delle Fave; A Morelli
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

3.  Pancreatic polypeptide response to a meal before and after cutting the extrinsic nerves of the upper gastrointestinal tract and the pancreas in the dog.

Authors:  W Niebel; V E Eysselein; M V Singer
Journal:  Dig Dis Sci       Date:  1987-09       Impact factor: 3.199

4.  The effect of intravenous cadmium on exocrine and endocrine pancreatic functions in conscious dogs.

Authors:  P Chowdhury; R Doi; K Inoue; P L Rayford
Journal:  Biol Trace Elem Res       Date:  1993-10       Impact factor: 3.738

5.  Physiologic role of cholecystokinin in the intestinal phase of pancreatic polypeptide release.

Authors:  G M Fried; W D Ogden; G H Greeley; J C Thompson
Journal:  Ann Surg       Date:  1984-11       Impact factor: 12.969

6.  Effects of endogenous and exogenous secretin on plasma pancreatic polypeptide concentrations in dogs.

Authors:  F Koizumi; A Ohkawa; T Kawamura; A Ishimori; I Sasaki; J Kameyama
Journal:  Diabetologia       Date:  1986-04       Impact factor: 10.122

7.  Neural pathways for the release of gastrin, cholecystokinin, and pancreatic polypeptide after a meal in dogs. Role of gastric and splanchnic nerves.

Authors:  C D Johnson; J A Chayvialle; M A Devaux; H Sarles
Journal:  Dig Dis Sci       Date:  1986-12       Impact factor: 3.199

8.  Release of cholecystokinin and gallbladder contraction before and after gastrectomy.

Authors:  K Inoue; A Fuchigami; R Hosotani; M Kogire; Y S Huang; T Miyashita; T Suzuki; K Tsuda; Y Seino; P L Rayford
Journal:  Ann Surg       Date:  1987-01       Impact factor: 12.969

9.  Abnormal pancreatic polypeptide release by secretin infusion in Zollinger-Ellison syndrome.

Authors:  D Rigaud; J P Accary; M Mignon; S Bonfils
Journal:  Dig Dis Sci       Date:  1984-08       Impact factor: 3.199

10.  The influence of cadmium (CdCl2) on the canine plasma levels of gastrin, cholecystokinin (CCK), and pancreatic polypeptide (PP).

Authors:  P Chowdhury; K Inoue; P L Rayford
Journal:  Biol Trace Elem Res       Date:  1984-06       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.